NCT06615726

Brief Summary

The objective of this study is to evaluate the effectiveness and safety of regular physical exercise in preventing ischemic stroke events in patients with symptomatic intracranial arterial stenosis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,300

participants targeted

Target at P75+ for phase_3

Timeline
7mo left

Started Oct 2024

Geographic Reach
1 country

58 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Oct 2024Nov 2026

First Submitted

Initial submission to the registry

September 24, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 27, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

October 10, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 19, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 19, 2026

Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

2.1 years

First QC Date

September 24, 2024

Last Update Submit

November 22, 2025

Conditions

Keywords

Ischemic strokeTransient Ischemic AttackSymptomatic intracranial arterial stenosis

Outcome Measures

Primary Outcomes (1)

  • New ischemic stroke events

    1 year

Secondary Outcomes (7)

  • New ischemic stroke and transient ischemic attack events in the responsible vessel supply area

    1 year

  • New ischemic stroke and transient ischemic attack events

    1 year

  • Hemorrhagic stroke event

    1 year

  • Myocardial infarction

    1 year

  • The proportion of modified Rankin Scale score 0-1 (range, 0 to 6, with higher scores indicating greater disability)

    1 year

  • +2 more secondary outcomes

Other Outcomes (2)

  • Falls

    1 year

  • All-cause death

    1 year

Study Arms (2)

regular physical exercise group

EXPERIMENTAL
Behavioral: Regular physical exercise

Control group

OTHER
Other: Control group

Interventions

Best medical treatment plus regular physical exercise. Each subject is equipped with an exercise guidance expert to regularly guide and adjust the exercise plan according to the subject's personal conditions throughout the trial period. After randomization, the exercise guidance expert formulated an individualized aerobic exercise plan based on the subject's preferences and their own exercise abilities. After each exercise, subjects filled out the exercise diary , and reported back to the exercise guidance expert.

regular physical exercise group

Best medical treatment

Control group

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥40 years and ≤80 years;
  • Ischemic stroke or TIA (transient ischemic attack) onset ≤30 days;
  • Ischemic stroke or TIA is attributed to 50-99% of the ICAS (internal carotid artery, M1 segment of middle cerebral artery, M2 segment of middle cerebral artery, basilar artery, or vertebral artery; the degree of stenosis is determined by magnetic resonance angiography, computed tomography angiography, digital subtraction angiography using the standards of warfarin-aspirin symptomatic intracranial disease );
  • mRS (modified Rankin Scale)≤4;
  • The patient himself or his legal representative signs the informed consent form.

You may not qualify if:

  • Stroke progression within the past 3 days (defined as an increase in the score of National Institute of Health Stroke Scale ≥4 points or an increase in individual items of ≥2 points).
  • mRS≥1 before the stroke onset.
  • Concurrent osteoarthritis, fracture, lower limb venous thrombosis, unstable angina pectoris, respiratory diseases, limb disabilities, etc., making it theoretically difficult to cooperate with the physical activity plan for this trial.
  • Complicated with motor disorders such as Parkinson\'s disease and Parkinson\'s syndrome.
  • The vessels responsible for this stroke had tandem lesions (more than 50% of extracranial artery stenosis).
  • The vessel responsible for this stroke has undergone intracranial balloon angioplasty and/or stent implantation (except for mechanical thrombectomy and/or aspiration alone).
  • It is expected that intracranial arterial balloon angioplasty and/or stent implantation will be performed on the vessel responsible for the stroke within 3 months.
  • Patients who exercised regularly within the last 6 months. Regular exercise is defined as four or more moderate intensity exercises per week for more than 10 minutes each time or two or more high intensity exercises per week for more than 10 minutes each time.
  • Inability to understand and/or comply with the trial procedures and/or follow-up due to mental illness, cognitive or emotional disorders.
  • Life expectancy is less than one year.
  • Women who are known to be pregnant or nursing, or have a positive pregnancy test;
  • Are participating in other drug or device research.
  • There are other circumstances that investigators consider are not suitable for enrollment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (58)

Taihe Hospital of Traditional Chinese Medicine

Fuyang, Anhui, China

Location

Huainan Sunshine Xinkang Hospital

Huainan, Anhui, China

Location

Suzhou Municipal Hospital

Suzhou, Anhui, 234000, China

Location

The Second People's Hospital of Wuhu

Wuhu, Anhui, China

Location

Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality, 100053, China

Location

Beijing Pinggu District Hospital

Beijing, Beijing Municipality, China

Location

Chongqing Sanbo Jiangling Hospital

Chongqing, Chongqing Municipality, China

Location

Zhangzhou Hospital

Zhangzhou, Fu, China

Location

Foshan Fifth People's Hospital

Foshan, Guangdong, China

Location

Foshan Nanhai District Sixth People's Hospital

Foshan, Guangdong, China

Location

Brain Hospital Affiliated to Guangzhou Medical University

Guangzhou, Guangdong, China

Location

Longchuan Hospital of Traditional Chinese Medicine

Heyuan, Guangdong, China

Location

Hospital 925, Joint Logistics Support Force

Guizhou, Guiyang, China

Location

Cangzhou People's Hospital of integrated Chinese and Western Medicine, Hebei Province

Cangzhou, Hebei, China

Location

Army Military Medical University Officer School affiliated hospital

Shijiazhuang, Hebei, China

Location

Tangshan Workers' Hospital

Tangshan, Hebei, China

Location

Ningjin County Hospital

Xingtai, Hebei, China

Location

Gongyi Xinhua Hospital of Traditional Chinese Medicine

Gongyi, Henan, China

Location

Tongxu First Hospital

Kaifeng, Henan, China

Location

Fangcheng County People's Hospital

Nanyang, Henan, China

Location

Nanyang City Center Hospital

Nanyang, Henan, China

Location

Shangqiu First People's Hospital

Shangqiu, Henan, China

Location

Yongcheng Central Hospital

Shangqiu, Henan, China

Location

The First Affiliated Hospital of Xinxiang Medical College

Xinxiang, Henan, China

Location

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, 450000, China

Location

Henan Provincial People's Hospital

Zhengzhou, Henan, China

Location

The First Affiliated Hospital of Henan University of Chinese Medicine

Zhengzhou, Henan, China

Location

Zhengzhou First People's Hospital

Zhengzhou, Henan, China

Location

Zhengzhou Zhongkang Hospital

Zhengzhou, Henan, China

Location

Zhongmou County People's Hospital

Zhengzhou, Henan, China

Location

Xihua County People's Hospital

Zhoukou, Henan, China

Location

Lichuan Ethnic Chinese Medicine Hospital

Lichuan, Hubei, China

Location

Hubei Third People's Hospital

Wuhan, Hubei, China

Location

Yueyang City People's Court

Yueyang, Hubei, China

Location

Liuyang City Jili Hospital

Guankou, Hunan, 410300, China

Location

Xiangtan Central Hospital

Xiangtan, Hunan, China

Location

Jiujiang First People's Hospital

Jiujiang, Jiangxi, China

Location

Jilin City People's Hospital

Jilin, Jilin, China

Location

Xinmin People's Hospital

Shenyang, Liaoning, China

Location

Affiliated Hospital of Inner Mongolia University for Nationalities

Tongliao, Neimenggu, China

Location

Yantai Yeda Hospital

Yantai, Shaanxi, China

Location

Shandong University Qilu Hospital Dezhou Hospital

Dezhou, Shandong, China

Location

Shengli Oilfield Central Hospital

Dongying, Shandong, China

Location

Jinan High-tech East District Hospital

Jinan, Shandong, China

Location

Laixi People's Hospital

Laixi, Shandong, China

Location

Liaocheng People's Hospital

Liaocheng, Shandong, China

Location

Lanshan District People's Hospital

Rizhao, Shandong, China

Location

Affiliated Hospital of Shandong Second Medical University

Weifang, Shandong, China

Location

Yantai Fushan District People's Hospital

Yantai, Shandong, China

Location

Tengzhou Central Hospital

Zaozhuang, Shandong, China

Location

Ningjin County People's Hospital

Dezhou, Shangdong, China

Location

Shanghai Hechuan Rhein Hospital of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, China

Location

Sichuan Academy of Sciences Hospital

Chengdu, Sichuan, China

Location

Jianyang City Hospital of Traditional Chinese Medicine

Jiancheng, Sichuan, China

Location

Ya 'an People's Hospital

Yaan, Sichuan, China

Location

Shihezi People's Hospital

Shihezi, Xinjiang, 836800, China

Location

Yongjia County People's Hospital

Wenzhou, Zhejiang, China

Location

Yueqing People's Hospital

Wenzhou, Zhejiang, China

Location

MeSH Terms

Conditions

Ischemic StrokeIschemic Attack, Transient

Interventions

Control Groups

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBrain Ischemia

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 24, 2024

First Posted

September 27, 2024

Study Start

October 10, 2024

Primary Completion (Estimated)

November 19, 2026

Study Completion (Estimated)

November 19, 2026

Last Updated

November 25, 2025

Record last verified: 2025-11

Locations